Influence of expiratory yoga techniques on respiratory function, physical activity, quality of life, and length of hospital stay in patients with pleural disorders: A Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 92
- 试验地点
- 1
- 主要终点
- 1.Pulmonary function test mainly FVC, FEV1will be use to assess respiratory function
研究概览
简要总结
The aim of the study is to the study effects of expiratory yoga techniques and conventional physiotherapy on respiratory function, physical activity, quality of life, and length of hospital stay. It is a randomized, open-label blinded, parallel-group, active-controlled trial single-center trial where two groups of patients with pleural disorders will be undergoing rehabilitation for 12 weeks. The physiotherapy group will receive pulmonary rehabilitation and the yoga group will receive both pulmonary rehabilitation and expiratory yoga techniques. The primary outcome measures are pulmonary function test, maximal inspiratory and maximal expiratory pressure, 6-minute walk test, IPAQ, WHOQOL-BREF, and length of hospital stay. Knowledge gained from the study will help provide scientific and evidence-based guidelines for patients with pleural disorders to improve respiratory function, physical activity, and quality of life.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with pleural effusion treated with or without ICD (J90) Patients with pleural effusion conditions classified elsewhere (J91) Patients with pleural plaque with presence of asbestos (J92.0) Patients with pleural plaque without asbestos (J92.9) Patients with Fibrothorax (J 94.1) Patients with other specified pleural conditions (J94.8) Patients with age 18-65 years.
排除标准
- •Patients with pleurisy Patients with multiple segmental fractures of ribs Patients with highly spread malignant tumors Patients with tension pneumothorax Patients with broncho-pleural fistulas Patients with age > 65 years Patients with morbidly obese Patients with other concomitant neurological Patients with recent trauma or surgery Patients with cognitive impairment or comprehension deficits that prevented them from following verbal commands.
结局指标
主要结局
1.Pulmonary function test mainly FVC, FEV1will be use to assess respiratory function
时间窗: Pre-intervention, at the 6th week of intervention and 12th week of intervention.
2.Maximum inspiratory pressure and maximum expiratory pressure will be use global measures of maximal strength of respiratory muscles.
时间窗: Pre-intervention, at the 6th week of intervention and 12th week of intervention.
3.6-minute walk test will be use to assess cardiopulmonary endurance.
时间窗: Pre-intervention, at the 6th week of intervention and 12th week of intervention.
4.IPAQ will be use to assess physical activity.
时间窗: Pre-intervention, at the 6th week of intervention and 12th week of intervention.
5.WHOQOL-BREF questionnaire will be use to assess quality of life
时间窗: Pre-intervention, at the 6th week of intervention and 12th week of intervention.
6.Length of hospital stay defined as the number of days between hospital admission and discharge
时间窗: Pre-intervention, at the 6th week of intervention and 12th week of intervention.
次要结局
未报告次要终点